Published in Hepatology on December 01, 1992
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg (2007) 2.53
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer (2004) 1.64
Snail accelerates cancer invasion by upregulating MMP expression and is associated with poor prognosis of hepatocellular carcinoma. Br J Cancer (2005) 1.51
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Clinical management of recurrent hepatocellular carcinoma. Ann Surg (1995) 1.16
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer (1998) 1.06
Viruses and hepatocellular carcinoma. Gut (1994) 0.96
High expression of Snail mRNA in blood from hepatocellular carcinoma patients with extra-hepatic metastasis. Clin Exp Metastasis (2009) 0.92
Is p53 gene mutation an indicatior of the biological behaviors of recurrence of hepatocellular carcinoma? World J Gastroenterol (2003) 0.87
Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg (2006) 0.84
Is the expression of gamma-glutamyl transpeptidase messenger RNA an indicator of biological behavior in recurrent hepatocellular carcinoma? World J Gastroenterol (2003) 0.81
Hepatitis C virus infection is a risk factor for tumor recurrence after resection of small hepatocellular carcinomas. World J Surg (2004) 0.80
Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J Surg (2002) 0.80
Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma. Int J Clin Oncol (2005) 0.79
Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma. World J Gastroenterol (2005) 0.79
Prognosis after hepatic resection in patients with hepatocellular carcinoma, estimated on the basis of the morphometric indices. Cancer Chemother Pharmacol (1994) 0.78
Prognosis of hepatocellular carcinoma after hepatectomy in patients with renal dysfunction. World J Surg (2005) 0.78
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrence. World J Surg (2004) 0.78
Effect of the pringle maneuver on tumor recurrence of hepatocellular carcinoma after curative resection (EPTRH): a randomized, prospective, controlled multicenter trial. BMC Cancer (2012) 0.77
Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma. PLoS One (2014) 0.76
Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy. World J Gastroenterol (2015) 0.75
Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases. World J Surg (2017) 0.75
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology (1998) 2.52
Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg (1996) 2.35
Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery (2000) 2.14
Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med (2000) 1.80
Sonography of acute right side colonic diverticulitis. Am J Surg (2001) 1.70
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer (2004) 1.64
Results of curative gastrectomy for carcinoma of the distal third of the stomach. J Am Coll Surg (1996) 1.64
Local thermal stimulation relaxes hypertonic anal sphincter: evidence of somatoanal reflex. Dis Colon Rectum (1999) 1.54
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma patients. J Gastroenterol (1998) 1.42
Randomized trial of gastrojejunostomy with duodenal partition versus antrectomy in unresectable periampullary cancer. Zhonghua Yi Xue Za Zhi (Taipei) (2001) 1.41
Expression of multiple oncogenes in human esophageal carcinomas. Cancer Invest (1994) 1.38
Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J Surg (2000) 1.37
Heterotopic pancreas: a difficult diagnosis. J Clin Gastroenterol (1999) 1.37
Mucin-producing neoplasms of the pancreas. Intraductal papillary and mucinous cystic neoplasms. Ann Surg (1996) 1.36
Mesenteric and omental cysts: an ultrasonographic and clinical study of 15 patients. Gastrointest Radiol (1991) 1.32
Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol (1999) 1.30
Analysis of hepatitis B virus transcripts in infected human livers. Hepatology (1989) 1.25
Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut (1996) 1.23
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol (1996) 1.22
Relative prevalence of gallstone diseases in Taiwan. A nationwide cooperative study. Dig Dis Sci (1992) 1.21
Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells. Eur J Clin Invest (2006) 1.20
IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int (2001) 1.19
Prospective case-controlled trial of adjuvant chemotherapy after resection of hepatocellular carcinoma. World J Surg (2000) 1.19
Characterization of glycine-N-methyltransferase-gene expression in human hepatocellular carcinoma. Int J Cancer (1998) 1.13
Laparoscopic cholecystectomy for cholelithiasis in a patient with situs inversus totalis. Endoscopy (1992) 1.11
Comparison of 2-methoxyestradiol-induced, docetaxel-induced, and paclitaxel-induced apoptosis in hepatoma cells and its correlation with reactive oxygen species. Cancer (2000) 1.07
Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer (2000) 1.07
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res (1998) 1.07
Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer (1998) 1.06
Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer (1996) 1.06
Distribution of the superficial temporal artery in the Chinese adult. Plast Reconstr Surg (1999) 1.06
Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci (1997) 1.05
Quality of life of patients with gastric adenocarcinoma after curative gastrectomy. World J Surg (1997) 1.04
Hepatolithiasis associated with cholangiocarcinoma. Br J Surg (1997) 1.03
Diverticular disease of the small bowel. Hepatogastroenterology (2000) 1.03
The formation of bile canaliculi in human hepatoma cell lines. Hepatology (1990) 1.02
Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma. Genomics (1998) 1.02
Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol (1996) 1.01
Diagnostic and prognostic values of CA 19-9 and CEA in periampullary cancers. J Am Coll Surg (1999) 1.01
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer (1999) 1.01
Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer (1996) 1.01
Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol (1997) 1.01
tie-1 protein tyrosine kinase: a novel independent prognostic marker for gastric cancer. Clin Cancer Res (1999) 1.00
High-level expression of a chemically synthesized gene for human interferon-gamma using a prokaryotic expression vector. Proc Natl Acad Sci U S A (1984) 1.00
Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg (1995) 1.00
Factors affecting morbidity and mortality in biliary tract surgery. World J Surg (1992) 0.99
Bile duct injury and bile leakage in laparoscopic cholecystectomy. Br J Surg (1993) 0.97
Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (1998) 0.94
Local somatothermal stimulation inhibits motility of the internal anal sphincter through nitrergic neural release of nitric oxide. Dis Colon Rectum (2000) 0.94
Family planning and child mental health in China: the Nanjing Survey. Am J Psychiatry (1988) 0.94
Life-threatening haemorrhage from a sternal metastatic hepatocellular carcinoma. J Gastroenterol Hepatol (2000) 0.94
Retroperitoneal cystic lymphangioma in adults. Int Surg (1994) 0.92
Up-regulation of multidrug resistance transporter expression by berberine in human and murine hepatoma cells. Cancer (1999) 0.92
In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sci (1997) 0.92
Somatic electrical nerve stimulation regulates the motility of sphincter of Oddi in rabbits and cats: evidence for a somatovisceral reflex mediated by cholecystokinin. Dig Dis Sci (1999) 0.91
Renal allograft dysfunction associated with rifampin-tacrolimus interaction. Ann Pharmacother (2000) 0.91
Factors affecting morbidity, mortality and survival after pancreaticoduodenectomy for carcinoma of the ampulla of Vater. Hepatogastroenterology (1999) 0.90
Preconditioning somatothermal stimulation on right seventh intercostal nerve territory increases hepatic heat shock protein 70 and protects the liver from ischemia-reperfusion injury in rats. J Surg Res (2001) 0.90
Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg (1998) 0.90
Central venous catheter-associated Nocardia bacteremia. Clin Infect Dis (2001) 0.90
Prediction of relapse or survival after resection in human hepatomas by DNA flow cytometry. J Clin Invest (1992) 0.89
Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma. J Gastroenterol Hepatol (1997) 0.89
Inflammatory fibroid polyp of stomach. Report of two cases and review of the literature. Zhonghua Yi Xue Za Zhi (Taipei) (1988) 0.89
Better post-resectional survival in female cirrhotic patients with hepatocellular carcinoma. Hepatogastroenterology (2000) 0.88
Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma. J Formos Med Assoc (1999) 0.88
Immunohistochemical study of arginase in cancer of the stomach. Virchows Arch (1996) 0.88
Prospective study of gastric outlet obstruction in unresectable periampullary adenocarcinoma. World J Surg (2000) 0.88
Hypercholesterolaemia in patients with hepatocellular carcinoma. J Gastroenterol Hepatol (1992) 0.88
Variations of the cystic artery in Chinese adults. Surg Laparosc Endosc Percutan Tech (2000) 0.88
Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases. J Gastroenterol Hepatol (1999) 0.88
Hepatocyte growth factor and Met/HGF receptors in patients with gastric adenocarcinoma. Oncol Rep (1998) 0.87